Danaher Eyes $10B Masimo Acquisition Amid Apple IP Fight
Healthcare giant Danaher is closing in on a roughly $10 billion deal to acquire pulse oximetry pioneer Masimo.
Danaher, one of the biggest names in US healthcare manufacturing, is reportedly on the verge of snapping up medtech firm Masimo in a deal worth approximately $10 billion.
Masimo is best known for its pulse oximetry technology — the kind that clips onto your finger and reads blood oxygen levels. The company has built a significant intellectual property portfolio around that tech, which brings us to the spicy subplot.
Masimo has been locked in a long-running IP battle with Apple over the Apple Watch's health-sensing features. That dispute remains unresolved and has already forced Apple to make changes to its flagship wearable.
If Danaher closes this deal, it would inherit that legal fight along with Masimo's broader medtech business. That's a $10 billion bet that comes with a side of courtroom drama against the world's most valuable company.